STOCKHOLM, Sweden, Oct. 28, 2005 (PRIMEZONE) -- DISCLOSURE NOTICE
Industrivarden has sold its remaining holding of 14,817,286 shares (corresponding to 3.85% of the votes and capital) in the Icelandic medical technology company Ossur hf.
The sale entails that Industrivarden has now divested its entire holding of 89,817,286 shares (corresponding to 23.33% of the votes and capital), for SEK 1,008 M. The sale of the entire holding in Ossur gives rise to a capital gain of SEK 398 M for Industrivarden.
Commenting on the sale of its holding in Ossur, Industrivarden's CEO, Anders Nyren said: "Industrivarden was the first international investor to recognize the excellent investment potential in Ossur. We have participated in the development of a company that has expanded strongly with good profitability. Our investment, excluding participation in the new issue of SEK 155 M in September and October, grew in value by approximately 90%. After slightly more than three years as an active owner, we have thus made a good deal with a substantial capital gain."
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=145809&fn=wkr0001.pdf